HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
REN
renin
Chromosome 1 Β· 1q32.1
NCBI Gene: 5972Ensembl: ENSG00000143839.16HGNC: HGNC:9958UniProt: P00797
278PubMed Papers
22Diseases
4Drugs
22Pathogenic Variants
FUNCTIONAL ROLE
Protease
RESEARCH IMPACT
Trending
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
peptidase activitykidney developmentsignaling receptor bindingregulation of MAPK cascadefamilial juvenile hyperuricemic nephropathy type 2renal tubular dysgenesisrenal tubular dysgenesis of genetic originHyperuricemia - anemia - renal failure
✦AI Summary

REN encodes renin, a highly specific aspartic-type endopeptidase that initiates the renin-angiotensin system by cleaving angiotensinogen to generate angiotensin I, thereby regulating blood pressure and sodium retention 1. Renin is secreted from juxtaglomerular cells and functions in the extracellular space and plasma to orchestrate this proteolytic cascade 2. Beyond its classical endocrine role, renin also functions as a tumor suppressor; REN/KCTD11 serves as a substrate receptor of the Cullin3-RING ubiquitin ligase complex (CRL3REN), mediating polyubiquitylation and degradation of oncogenic proteins, with loss of REN occurring in approximately 30% of Sonic Hedgehog-dependent medulloblastomas 3. Mutations in REN cause autosomal dominant tubulointerstitial kidney disease (ADTKD-REN), characterized by progressive renal dysfunction with tubular atrophy and interstitial fibrosis 4. Affected patients present with distinctive signs of hyporeninemia including mild hypotension, mild hyperkalemia, childhood anemia, hyperuricemia, and gout in teenage years, with a median age at end-stage renal disease of approximately 45 years 2. Genetic testing rather than kidney biopsy is recommended for diagnosis of REN-related disease 2.

Sources cited
1
REN mutations cause autosomal dominant interstitial kidney disease with anemia, hyperuricemia, hyperkalemia, and progressive kidney disease
PMID: 20807609
2
ADTKD-REN is associated with hyporeninemia signs, mean ESRD age ~45 years, and genetic testing is diagnostic method
PMID: 28284384
3
REN/KCTD11 is a tumor suppressor functioning as CRL3REN substrate receptor mediating protein degradation, lost in ~30% of SHH-medulloblastomas
PMID: 38062245
4
REN variants identified in ADTKD patients with tubular atrophy, interstitial fibrosis, and progressive kidney dysfunction
PMID: 39976632
⚠Limited data available β€” This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜22
familial juvenile hyperuricemic nephropathy type 2Open Targets
0.77Strong
renal tubular dysgenesisOpen Targets
0.75Strong
renal tubular dysgenesis of genetic originOpen Targets
0.74Strong
Hyperuricemia - anemia - renal failureOpen Targets
0.68Moderate
hypertensionOpen Targets
0.66Moderate
strokeOpen Targets
0.47Moderate
cardiovascular diseaseOpen Targets
0.43Moderate
genetic disorderOpen Targets
0.41Moderate
essential hypertensionOpen Targets
0.39Weak
congenital anomaly of kidney and urinary tractOpen Targets
0.37Weak
heart failureOpen Targets
0.37Weak
diabetes mellitusOpen Targets
0.36Weak
atrial fibrillationOpen Targets
0.28Weak
IGA glomerulonephritisOpen Targets
0.27Weak
blood coagulation diseaseOpen Targets
0.27Weak
myocardial infarctionOpen Targets
0.27Weak
kidney failureOpen Targets
0.27Weak
congestive heart failureOpen Targets
0.27Weak
placenta praeviaOpen Targets
0.27Weak
endothelial dysfunctionOpen Targets
0.26Weak
Renal tubular dysgenesisUniProt
Tubulointerstitial kidney disease, autosomal dominant 4UniProt
Pathogenic Variants22
NM_000537.4(REN):c.415A>T (p.Lys139Ter)Pathogenic
not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 139
NM_000537.4(REN):c.36GCT[3] (p.Leu16del)Pathogenic
Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 16
NM_000537.4(REN):c.249+1G>APathogenic
not provided|Familial juvenile hyperuricemic nephropathy type 2;Renal tubular dysgenesis of genetic origin|Familial juvenile hyperuricemic nephropathy type 2
β˜…β˜…β˜†β˜†2024
NM_000537.4(REN):c.145C>T (p.Arg49Ter)Pathogenic
Renal tubular dysgenesis|Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 49
NM_000537.4(REN):c.58T>C (p.Cys20Arg)Pathogenic
Familial juvenile hyperuricemic nephropathy type 2|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 20
NM_000537.4(REN):c.49T>C (p.Trp17Arg)Pathogenic
Familial juvenile hyperuricemic nephropathy type 2
β˜…β˜†β˜†β˜†2025β†’ Residue 17
NM_000537.4(REN):c.30G>A (p.Trp10Ter)Likely pathogenic
Familial juvenile hyperuricemic nephropathy type 2
β˜…β˜†β˜†β˜†2025β†’ Residue 10
NM_000537.4(REN):c.951dup (p.Leu318fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 318
NM_000537.4(REN):c.1172_1173del (p.Thr391fs)Likely pathogenic
Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2
β˜…β˜†β˜†β˜†2024β†’ Residue 391
NM_000537.4(REN):c.250-1delLikely pathogenic
Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2
β˜…β˜†β˜†β˜†2024
NM_000537.4(REN):c.249+1G>TLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_000537.4(REN):c.127C>T (p.Arg43Ter)Pathogenic
Renal tubular dysgenesis|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2
β˜…β˜†β˜†β˜†2022β†’ Residue 43
NM_000537.4(REN):c.77C>T (p.Thr26Ile)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 26
NM_000537.4(REN):c.799del (p.Trp267fs)Likely pathogenic
Renal tubular dysgenesis
β˜†β˜†β˜†β˜†2024β†’ Residue 267
NM_000537.4(REN):c.1079dup (p.Leu361fs)Likely pathogenic
Familial juvenile hyperuricemic nephropathy type 2
β˜†β˜†β˜†β˜†2024β†’ Residue 361
NM_000537.4(REN):c.299_300del (p.Lys100fs)Pathogenic
Renal tubular dysgenesis
β˜†β˜†β˜†β˜†2021β†’ Residue 100
NM_000537.4(REN):c.116T>A (p.Met39Lys)Likely pathogenic
not provided
β˜†β˜†β˜†β˜†2018β†’ Residue 39
NM_000537.4(REN):c.47T>A (p.Leu16His)Likely pathogenic
Familial juvenile hyperuricemic nephropathy type 2
β˜†β˜†β˜†β˜†2017β†’ Residue 16
NM_000537.4(REN):c.404C>A (p.Ser135Tyr)Pathogenic
Renal tubular dysgenesis
β˜†β˜†β˜†β˜†2011β†’ Residue 135
NM_000537.4(REN):c.47T>G (p.Leu16Arg)Pathogenic
Familial juvenile hyperuricemic nephropathy type 2
β˜†β˜†β˜†β˜†2009β†’ Residue 16
View on ClinVar β†—
Drug Targets4
ALISKIRENApproved
Renin inhibitor
cardiovascular disease
ALISKIREN FUMARATEApproved
Renin inhibitor
hypertension
IMARIKIREN HYDROCHLORIDEPhase II
Renin inhibitor
type 2 diabetes mellitus
SITOKIRENPhase II
Renin inhibitor
ulcerative colitis
Related Genes
KLProtein interaction100%ATP6AP2Protein interaction100%IL6Protein interaction96%NR3C2Protein interaction94%NPPAProtein interaction94%AGTR2Protein interaction94%
Tissue Expression6 tissues
Ovary
100%
Liver
14%
Lung
2%
Brain
2%
Bone Marrow
0%
Heart
0%
Gene Interaction Network
Click a node to explore
RENKLATP6AP2IL6NR3C2NPPAAGTR2
PROTEIN STRUCTURE
Preparing viewer…
PDB3K1W Β· 1.50 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.07LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.83 [0.65–1.07]
RankingsWhere REN stands among ~20K protein-coding genes
  • #1,306of 20,598
    Most Researched278 Β· top 10%
  • #537of 1,025
    FDA-Approved Drug Targets2
  • #2,087of 5,498
    Most Pathogenic Variants22
  • #10,783of 17,882
    Most Constrained (LOEUF)1.07
Genes detectedREN
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
PMID: 37500296
Trends Pharmacol Sci Β· 2023
1.00
2
Mapping human epigenomes.
PMID: 24074860
Cell Β· 2013
0.90
3
SALL4 is a CRL3
PMID: 38062245
Cell Death Differ Β· 2024
0.80
4
SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance.
PMID: 33558684
Cell Mol Immunol Β· 2021
0.70
5
In silico analysis of human renin gene-gene interactions and neighborhood topologically associated domains suggests breakdown of insulators contribute to ageing-associated diseases.
PMID: 31520345
Biogerontology Β· 2019
0.64